Last week Pear Therapeutics trumpeted the creation of new reimbursement codes by the Centers for Medicare and Medicaid for its three approved digital therapies, saying this was a step towards more widespread coverage of this category of medical device.
But Pear was not the only company to have its innovative devices recognised by the CMS as worthy of simplified reimbursement. Outset Medical, maker of a portable dialysis system, and the sleep apnoea specialist Signifier Medical Technologies are also beneficiaries, and could see their sales rise as a result.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,